Several recent studies have suggested that GLP-1 should be considered as a treatment for a wide range of intestinal diseases, including Inflammatory bowel diseases, intestinal mucositis, coeliac disease and short bowel syndrome (45). Here, GLP1R is linked to inflammatory bowel disease.